Page last updated: 2024-10-23

berberine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

berberine has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 2 studies

Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.

Research Excerpts

ExcerptRelevanceReference
"Treating BCR-ABL-positive chronic myeloid leukemia remains impeded by the development of clinical resistance to imatinib."1.56"All Our Wisdom is Stored in the Trees" - Degrading BCR-ABL with ( Elf, SE, 2020)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Huang, G1
Yin, Z1
Wang, X1
Wen, Z1
Su, R1
Li, C1
Liu, Y1
Yang, J1
Hu, H1
Nie, H1
Zeng, X1
Fei, J1
Elf, SE1

Other Studies

2 other studies available for berberine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ArticleYear
System analysis of Huang-Lian-Jie-Du-Tang and their key active ingredients for overcoming CML resistance by suppression of leukemia stem cells.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2023, Volume: 117

    Topics: Animals; Berberine; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate;

2023
"All Our Wisdom is Stored in the Trees" - Degrading BCR-ABL with
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2020, 08-01, Volume: 26, Issue:15

    Topics: Antineoplastic Agents; Benzamides; Berberine; Berberis; Drug Resistance, Neoplasm; Fusion Proteins,

2020